Human Dihydropyrimidine Dehydrogenase (DPYD) ELISA Kit

Quantitative measurement of Dihydropyrimidine Dehydrogenase (DPYD) in human specimens is supported by this colorimetric immunoassay from Assay Genie, formatted as a 96-assay research kit. DPYD functions as the initial and rate-limiting enzyme in pyrimidine catabolism, and it is widely studied in oncology and pharmacogenomics research because of its central role in clearing fluoropyrimidine chemotherapy agents such as 5-fluorouracil and capecitabine. Investigating DPYD expression helps researchers explore inherited enzyme deficiency and the elevated risk of severe adverse reactions in affected patients.

The kit accommodates tissue homogenate and other clinical specimen types, and each package includes pre-coated plate wells, detection reagents, reference standards, and assay buffer components sufficient to complete the analysis. Standard laboratory ELISA workflows apply, making the kit accessible to researchers in clinical chemistry, translational pharmacology, and cancer biology laboratories who are characterizing DPYD as a biomarker of drug metabolism capacity.

The assay is intended for research use only and should be stored refrigerated until first use. Each kit is supplied for 96 assays, supporting moderate-throughput screening of clinical research cohorts or experimental samples. Researchers investigating nucleotide metabolism disorders, chemotherapy toxicity prediction, and individualized treatment strategies for colorectal, gastric, and breast cancers find this kit a practical tool for quantitative DPYD measurement in translational studies.